Auna S.A.

NYSE:AUNA

Medical - Care Facilities

Healthcare
$4.18 +1.47%

+$0.08 today

Market cap
$309.56M
Beta
0.81
P/E (TTM)
18.7
EPS (TTM)
$0.94
52W Low $4.09High $6.85

Volume 0.41M

Average 0.33M

AUNA Inventory

Cash effect of the change in inventory; building inventory consumes cash.

Auna S.A.NYSE: AUNA

Inventory · Q1 FY2026 · quarter ended Mar 2026

Inventory dips below year-ago levels

Q1 FY2026 inventory of PEN 11.18M fell 55.6% year over year, behind the +365.3% change in trailing-twelve-month inventory. Over 3 fiscal years it compounded at -9.8% a year.

Context

  • Inventory amounted to 0.4% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Inventory grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -55.6% toward the trailing-twelve-month pace of +365.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
PEN 11.18M+168.4% QoQ
Last fiscal yearDec 2025
-PEN 16.82M-34.9% YoY
LTMMar 2026
-PEN 31.78M+365.3% YoY
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-55.6%——
1 year-34.9%——
3-year CAGR-9.8%——
5-year CAGR——
10-year CAGR——

Inventory history

PEN · from the cash flow

Latest · FY2025
(16.82M) PEN
Year-over-year change
+34.9%

Inventory vs competitors

How AUNA compares with its peers on the latest reported figures

  • Peers report in different currencies, so inventory is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +365.3% is the 2nd highest of 6, against a peer median of +175.7%.
  • Inventory amounts to 0.7% of revenue for AUNA, versus a peer median of 0.6%.
AUNA Competitors
Inventory for AUNA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AUNAAuna S.A.LTM Mar 2026PEN 31.78M PEN+365.3%-9.8%0.7%
AUTLAutolus Therapeutics plcLTM Mar 2026$15.14M USD+249.9%—16.4%
TOIThe Oncology Institute, Inc.LTM Mar 2026$11.98M USD+1489.1%+58.0%2.2%
KIDSOrthoPediatrics Corp.LTM Mar 2026$6.42M USD-24.2%-20.6%2.6%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$1.57M USD+175.7%—0.8%
CBLLCeriBell, Inc.LTM Mar 2026$348K USD+1.2%-43.1%0.4%
AGLAgilon Health, Inc.LTM Mar 2026$0 USD——0.0%
SNDASonida Senior Living, Inc.LTM Mar 2026$0 USD——0.0%
CCRNCross Country Healthcare, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding AUNA) —+175.7%-20.6%0.6%

Competitors are the stored peer set for AUNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

PEN
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(23.02M)(76.83M)(214.34M)123.96M92.01M
Depreciation & Amortization77.4M138.09M235.75M219.15M209.67M
Deferred Income Tax19.9M29.38M90.17M59.82M0
Stock-Based Compensation003.68M9.15M0
Change in Working Capital49.03M(174.07M)(140.45M)(172.57M)(49.07M)
Accounts Receivables(39.47M)(80.48M)(316M)(343.15M)(76.95M)
Inventory(10.78M)(22.91M)(30.11M)(25.85M)(16.82M)
Accounts Payables000060.9M
Other Working Capital99.28M(70.68M)205.66M196.43M(16.2M)
Other Non-Cash Items60.05M246.07M607.61M429M(9.78M)
Operating Cash Flow183.34M162.64M582.41M668.5M242.83M
Capital Expenditures(289.37M)(151.97M)(165.17M)(90.86M)(81.08M)
Acquisitions (Net)(3.91M)(2.95B)(96.14M)(47.17M)6.13M
Purchases of Investments00(22.25M)00
Sales of Investments000071.34M
Other Investing Activities(54.83M)(153.83M)61.48M(98.79M)(19.93M)
Investing Cash Flow(291.99M)(3.21B)(173.15M)(236.82M)(78.83M)
Debt Repayment3.08M1.91B308.02M68.27M31.38M
Common Stock Issued0001.27B0
Common Stock Repurchased00000
Dividends Paid0(131K)(6.84M)(1.15M)0
Other Financing Activities(105.21M)1.22B(671.18M)(1.75B)(105.68M)
Financing Cash Flow(102.13M)3.13B(370M)(418.12M)(74.31M)
Effect of Forex Changes6.1M(14.07M)(6.82M)(18.95M)34.74M
Net Change in Cash(204.68M)69.92M32.44M(5.39M)124.43M
Free Cash Flow(106.03M)10.67M417.25M577.64M161.76M

Auna S.A.

NYSE:AUNA

Intrinsic Alpha fair value

Locked

Current Price

$4.18

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.